,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-08-19 08:00:00,The following are the top rated Healthcare stocks according to Validea's Patient Investor model based on the published strategy of Warren Buffett .,0.043228548020124435,0.004656202159821987,0.9521152973175049,neutral,0.038572344928979874
1,2018-08-19 08:00:00,"This strategy seeks out firms with long-term, predictable profitability and low debt that trade at reasonable valuations.",0.20986133813858032,0.006538537796586752,0.7836001515388489,neutral,0.20332279801368713
2,2018-08-19 08:00:00,NOVO NORDISK A/S (ADR) ( NVO ) is a large-cap growth stock in the Biotechnology & Drugs industry.,0.6795129776000977,0.009817813523113728,0.3106692135334015,positive,0.6696951389312744
3,2018-08-19 08:00:00,The rating according to our strategy based on Warren Buffett is 85% based on the firm's underlying fundamentals and the stock's valuation.,0.03404536843299866,0.004937018267810345,0.9610175490379333,neutral,0.029108349233865738
4,2018-08-19 08:00:00,A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.,0.16861788928508759,0.00888283085078001,0.8224993348121643,neutral,0.1597350537776947
5,2018-08-19 08:00:00,Company Description: Novo Nordisk A/S is a global healthcare company engaged in diabetes care.,0.035165395587682724,0.005260150413960218,0.9595745205879211,neutral,0.029905244708061218
6,2018-08-19 08:00:00,"The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products.",0.0315292663872242,0.004542067646980286,0.9639286994934082,neutral,0.026987198740243912
7,2018-08-19 08:00:00,"The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals.",0.01680627465248108,0.006854896433651447,0.9763388633728027,neutral,0.009951378218829632
8,2018-08-19 08:00:00,"The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs.",0.018632207065820694,0.0064317830838263035,0.9749360084533691,neutral,0.012200424447655678
9,2018-08-19 08:00:00,"The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy.",0.01864084042608738,0.005659011192619801,0.9757000803947449,neutral,0.012981829233467579
10,2018-08-19 08:00:00,The Company also offers Saxenda product to treat obesity.,0.16317449510097504,0.006714339833706617,0.8301112055778503,neutral,0.15646015107631683
11,2018-08-19 08:00:00,"It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem.",0.03718378394842148,0.004515387117862701,0.9583008289337158,neutral,0.03266839683055878
12,2018-08-19 08:00:00,"As of December 31, 2016, it marketed its products in over 180 countries.",0.029345368966460228,0.004965704400092363,0.9656888842582703,neutral,0.024379665032029152
13,2018-08-19 08:00:00,Its regional structure consists of two commercial units: North America and International Operations.,0.010657599195837975,0.008738992735743523,0.9806033968925476,neutral,0.001918606460094452
14,2018-08-19 08:00:00,The following table summarizes whether the stock meets each of this strategy's tests.,0.05868730694055557,0.005839604884386063,0.9354730844497681,neutral,0.05284770205616951
15,2018-08-19 08:00:00,"Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.",0.023617705330252647,0.009007120504975319,0.9673751592636108,neutral,0.014610584825277328
16,2018-08-19 08:00:00,"For a full detailed analysis using NASDAQ's Guru Analysis tool, click here

RESMED INC. ( RMD ) is a large-cap growth stock in the Medical Equipment & Supplies industry.",0.4909217357635498,0.009089389815926552,0.4999889135360718,neutral,0.481832355260849
17,2018-08-19 08:00:00,The rating according to our strategy based on Warren Buffett is 85% based on the firm's underlying fundamentals and the stock's valuation.,0.03404536843299866,0.004937018267810345,0.9610175490379333,neutral,0.029108349233865738
18,2018-08-19 08:00:00,A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.,0.16861788928508759,0.00888283085078001,0.8224993348121643,neutral,0.1597350537776947
19,2018-08-19 08:00:00,Company Description: ResMed Inc. is a holding company.,0.011859034188091755,0.008771237917244434,0.9793696999549866,neutral,0.0030877962708473206
20,2018-08-19 08:00:00,"The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases.",0.027518082410097122,0.005767699331045151,0.9667142629623413,neutral,0.02175038307905197
21,2018-08-19 08:00:00,SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep.,0.014162048697471619,0.0436302125453949,0.9422076940536499,neutral,-0.02946816384792328
22,2018-08-19 08:00:00,"Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes.",0.1623900681734085,0.0057306899689137936,0.8318792581558228,neutral,0.15665937960147858
23,2018-08-19 08:00:00,"The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.",0.019883422181010246,0.005442950874567032,0.9746736884117126,neutral,0.014440471306443214
24,2018-08-19 08:00:00,"The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.",0.03662538155913353,0.005017058923840523,0.9583575129508972,neutral,0.03160832077264786
25,2018-08-19 08:00:00,The following table summarizes whether the stock meets each of this strategy's tests.,0.05868730694055557,0.005839604884386063,0.9354730844497681,neutral,0.05284770205616951
26,2018-08-19 08:00:00,"Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.",0.023617705330252647,0.009007120504975319,0.9673751592636108,neutral,0.014610584825277328
27,2018-08-19 08:00:00,"For a full detailed analysis using NASDAQ's Guru Analysis tool, click here

INTUITIVE SURGICAL, INC. ( ISRG ) is a large-cap growth stock in the Medical Equipment & Supplies industry.",0.637584924697876,0.010514910332858562,0.3519001305103302,positive,0.6270700097084045
28,2018-08-19 08:00:00,The rating according to our strategy based on Warren Buffett is 77% based on the firm's underlying fundamentals and the stock's valuation.,0.030332785099744797,0.005116732325404882,0.9645504951477051,neutral,0.025216052308678627
29,2018-08-19 08:00:00,A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.,0.16861788928508759,0.00888283085078001,0.8224993348121643,neutral,0.1597350537776947
30,2018-08-19 08:00:00,"Company Description: Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories.",0.02185518853366375,0.006197228562086821,0.9719475507736206,neutral,0.015657959505915642
31,2018-08-19 08:00:00,"The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system.",0.020238682627677917,0.007399392314255238,0.9723619222640991,neutral,0.01283929031342268
32,2018-08-19 08:00:00,"The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.",0.02189486473798752,0.010379241779446602,0.9677258729934692,neutral,0.011515622958540916
33,2018-08-19 08:00:00,"The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition ( HD ) vision.",0.14674335718154907,0.005833636038005352,0.8474230170249939,neutral,0.14090971648693085
34,2018-08-19 08:00:00,"Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System.",0.08619140088558197,0.005270529538393021,0.9085380434989929,neutral,0.08092087507247925
35,2018-08-19 08:00:00,The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.,0.01875384896993637,0.00609822990372777,0.9751479625701904,neutral,0.012655619531869888
36,2018-08-19 08:00:00,The following table summarizes whether the stock meets each of this strategy's tests.,0.05868730694055557,0.005839604884386063,0.9354730844497681,neutral,0.05284770205616951
37,2018-08-19 08:00:00,"Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.",0.023617705330252647,0.009007120504975319,0.9673751592636108,neutral,0.014610584825277328
38,2018-08-19 08:00:00,"For a full detailed analysis using NASDAQ's Guru Analysis tool, click here

JOHNSON & JOHNSON ( JNJ ) is a large-cap growth stock in the Biotechnology & Drugs industry.",0.3862921893596649,0.00812978483736515,0.6055780053138733,neutral,0.3781624138355255
39,2018-08-19 08:00:00,The rating according to our strategy based on Warren Buffett is 72% based on the firm's underlying fundamentals and the stock's valuation.,0.030370399355888367,0.005157763138413429,0.9644718766212463,neutral,0.025212636217474937
40,2018-08-19 08:00:00,A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.,0.16861788928508759,0.00888283085078001,0.8224993348121643,neutral,0.1597350537776947
41,2018-08-19 08:00:00,"Company Description: Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field.",0.022640500217676163,0.005321762058883905,0.9720377326011658,neutral,0.017318738624453545
42,2018-08-19 08:00:00,"It operates through three segments: Consumer, Pharmaceutical and Medical Devices.",0.01738046668469906,0.005621119402348995,0.9769983887672424,neutral,0.011759347282350063
43,2018-08-19 08:00:00,Its primary focus is products related to human health and well-being.,0.0199076309800148,0.005109203513711691,0.9749831557273865,neutral,0.014798427000641823
44,2018-08-19 08:00:00,"The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets.",0.026238247752189636,0.004700914490967989,0.9690607786178589,neutral,0.021537333726882935
45,2018-08-19 08:00:00,"The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases.",0.02342440001666546,0.005434724502265453,0.9711408615112305,neutral,0.01798967644572258
46,2018-08-19 08:00:00,"The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields.",0.026487980037927628,0.004534867592155933,0.9689772129058838,neutral,0.02195311337709427
47,2018-08-19 08:00:00,"Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.",0.02322595752775669,0.005977198947221041,0.9707968235015869,neutral,0.017248759046196938
48,2018-08-19 08:00:00,The following table summarizes whether the stock meets each of this strategy's tests.,0.05868730694055557,0.005839604884386063,0.9354730844497681,neutral,0.05284770205616951
49,2018-08-19 08:00:00,"Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.",0.023617705330252647,0.009007120504975319,0.9673751592636108,neutral,0.014610584825277328
50,2018-08-19 08:00:00,"For a full detailed analysis using NASDAQ's Guru Analysis tool, click here

Since its inception, Validea's strategy based on Warren Buffett has returned 221.76% vs. 168.50% for the S&P 500.",0.4858311712741852,0.47629305720329285,0.03787573054432869,positive,0.009538114070892334
51,2018-08-19 08:00:00,"For more details on this strategy, click here

About Warren Buffett : Warren Buffett is considered by many to be the greatest investor of all time.",0.1991606056690216,0.011050635948777199,0.7897887825965881,neutral,0.18810996413230896
52,2018-08-19 08:00:00,"As the chairman of Berkshire Hathaway, Buffett has consistently outperformed the S&P 500 for decades, and in the process has become one of the world's richest men.",0.7431123852729797,0.038232944905757904,0.21865463256835938,positive,0.7048794627189636
53,2018-08-19 08:00:00,(Forbes puts his net worth at $37 billion.),0.021339498460292816,0.011338518932461739,0.967322051525116,neutral,0.010000979527831078
54,2018-08-19 08:00:00,"Despite his fortune, Buffett is known for living a modest lifestyle, by billionaire standards.",0.03567022085189819,0.03917572647333145,0.9251540899276733,neutral,-0.003505505621433258
55,2018-08-19 08:00:00,"His primary residence remains the gray stucco Nebraska home he purchased for $31,500 nearly 50 years ago, according to Forbes, and his folksy Midwestern manner and penchant for simple pleasures -- a cherry Coke, a good burger, and a good book are all near the top of the list -- have been well-documented.",0.10358904302120209,0.011022992432117462,0.8853879570960999,neutral,0.09256605058908463
56,2018-08-19 08:00:00,About Validea : Validea is an investment research service that follows the published strategies of investment legends.,0.01593991555273533,0.006665502674877644,0.9773945808410645,neutral,0.009274412877857685
57,2018-08-19 08:00:00,"Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig.",0.08751808106899261,0.010206557810306549,0.9022753238677979,neutral,0.07731152325868607
58,2018-08-19 08:00:00,"For more information about Validea, click here

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.009221813641488552,0.018771808594465256,0.9720064401626587,neutral,-0.009549994952976704
